• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Warby Parker Announces First Quarter 2025 Results

    5/8/25 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care
    Get the next $WRBY alert in real time by email

    Net revenue increased 12% year over year to $224 million

    Active Customers increased 9% on a trailing 12-month basis

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2025.

    "Our team delivered a strong start to 2025. We opened 11 net new stores, exceeded profitability expectations, drove the highest e-commerce growth we've seen since 2021, and delivered our seventh consecutive quarter of accelerating active customer growth," shared Co-Founder and Co-CEO Neil Blumenthal.

    "Looking to the rest of the year, we'll leverage our diversified supply chain and the strength of our tenured team to deliver on our strategic priorities. We believe our brand's strength, commitment to innovation, and differentiated value proposition reinforce Warby Parker's ability to continue taking share in the months and years ahead," added Co-Founder and Co-CEO Dave Gilboa.

    First Quarter 2025 Highlights

    • Net revenue increased $23.8 million, or 11.9%, to $223.8 million, as compared to the prior year period.
    • Active Customers increased 8.7% to 2.57 million on a trailing 12-month basis, and Average Revenue per Customer increased 4.8% to $310.
    • GAAP net income improved $6.2 million to $3.5 million, the Company's first quarter of positive net income as a public company.
    • Adjusted EBITDA(1) increased $6.8 million to $29.2 million, and Adjusted EBITDA Margin(1) increased 1.9 points to 13.1%.
    • Net cash provided by operating activities of $29.4 million.
    • Free Cash Flow(1) of $13.2 million.
    • Opened 11 net new stores during the quarter, ending Q1 with 287 stores.

    First Quarter 2025 Year Over Year Financial Results

    • Net revenue increased $23.8 million, or 11.9%, to $223.8 million.
    • Active Customers increased 8.7% to 2.57 million on a trailing 12-month basis, and Average Revenue per Customer increased 4.8% to $310.
    • Gross margin was 56.3% compared to 56.7% in the prior year. The decrease in gross margin was primarily driven by the sales growth of contact lenses and increased store occupancy costs, partially offset by increased penetration of our higher priced frames and lenses and lower outbound customer shipping costs as a percent of revenue.
    • Selling, general, and administrative expenses ("SG&A") were $123.5 million, up $4.9 million from the prior year, and represented 55.2% of revenue, down from 59.3% in the prior year. As a percentage of revenue, SG&A decreased primarily due to leverage from lower stock-based compensation costs and corporate expenses. Adjusted SG&A(1) was $110.3 million, or 49.3% of revenue, compared to $103.4 million, or 51.7% of revenue in the prior year.
    • GAAP net income improved $6.2 million to $3.5 million, primarily as a result of leveraging our expense base on higher revenue.
    • Adjusted EBITDA(1) increased $6.8 million to $29.2 million, and Adjusted EBITDA Margin(1) increased 1.9 points to 13.1%.

    Balance Sheet Highlights

    Warby Parker ended the first quarter of 2025 with $265.1 million in cash and cash equivalents.

    2025 Outlook

    For the full year 2025, Warby Parker is revising its guidance as follows:

    • Net revenue of $869 million to $886 million, representing growth of approximately 13% to 15%.
    • Adjusted EBITDA(1) of $91 million to $97 million, representing an Adjusted EBITDA Margin(1) of approximately 10.5% to 11.0%. Assumes the Company successfully mitigates the significant majority of tariffs at the current rates.
    • On track to open 45 new stores, including five shop-in-shops at select Target locations slated to open in the second half of the year.

    "We're pleased to have delivered solid Q1 results, reflecting continued double digit revenue growth paired with strong incremental adjusted EBITDA," said Chief Financial Officer Steve Miller. "These results underscore our disciplined execution and our continued ability to scale sustainably."

    The guidance and forward-looking statements made in this press release and on our conference call are based on management's expectations as of the date of this press release.

    (1) Please see the reconciliation of non-GAAP financial measures to the most comparable GAAP financial measure in the section titled "Non-GAAP Financial Measures" below.

    Webcast and Conference Call

    A conference call to discuss Warby Parker's first quarter 2025 results, as well as second quarter and full year 2025 outlook, is scheduled for 8:00 a.m. ET on May 8, 2025. To participate, please dial 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 020310. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where presentation materials will also be posted prior to the conference call. A replay will be made available online approximately two hours following the live call for a period of 90 days.

    Forward-Looking Statements

    This press release and the related conference call, webcast and presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, expectations of future operating results or financial performance, including expectations regarding achieving profitability and growth in our e-commerce channel, delivering stakeholder value, growing market share, and our guidance for the quarter ending June 30, 2025 and year ending December 31, 2025; expectations regarding the number of new store openings during the year ending December 31, 2025; management's plans, priorities, initiatives and strategies; expectations regarding growth of our business; and expectations regarding our ability to mitigate the impacts of existing or new tariffs. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "toward," "will," or "would," or the negative of these words or other similar terms or expressions. You should not put undue reliance on any forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved, if at all.

    Forward-looking statements are based on information available at the time those statements are made and are based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control, that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. These risks and uncertainties include our ability to manage our future growth effectively; our expectations regarding cost of goods sold, gross margin, channel mix, customer mix, and selling, general, and administrative expenses; increases in component and shipping costs and changes in supply chain; changes to U.S. or other countries' trade policies and tariff and import/export regulations; our reliance on our information technology systems and enterprise resource planning systems for our business to effectively operate and safeguard confidential information; our ability to invest in and incorporate new technologies into our products and services; risks related to our use of artificial intelligence; our ability to engage our existing customers and obtain new customers; our ability to expand in-network access with insurance providers; planned new retail stores in 2025 and going forward; an overall decline in the health of the economy and other factors impacting consumer spending, such as recessionary conditions, inflation, infectious diseases, government instability, and geopolitical unrest; our ability to compete successfully; our ability to manage our inventory balances and shrinkage; the growth of our brand awareness; our ability to recruit and retain optometrists, opticians, and other vision care professionals; the effects of seasonal trends on our results of operations; our ability to stay in compliance with extensive laws and regulations that apply to our business and operations; our ability to adequately maintain and protect our intellectual property and proprietary rights; our reliance on third parties for our products, operation and infrastructure; our duties related to being a public benefit corporation; the ability of our Co-Founders and Co-CEOs to exercise significant influence over all matters submitted to stockholders for approval; the effect of our multi-class structure on the trading price of our Class A common stock; and the increased expenses associated with being a public company. Additional information regarding these and other risks and uncertainties that could cause actual results to differ materially from the Company's expectations is included in our most recent reports filed with the SEC on Form 10-K and Form 10-Q. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

    Additional information regarding these and other factors that could affect the Company's results is included in the Company's SEC filings, which may be obtained by visiting the SEC's website at www.sec.gov. Information contained on, or that is referenced or can be accessed through, our website does not constitute part of this document and inclusions of any website addresses herein are inactive textual references only.

    Glossary

    Active Customers is defined as unique customer accounts that have made at least one purchase in the preceding 12-month period.

    Average Revenue per Customer is defined as the sum of the total net revenues in the preceding 12-month period divided by the current period Active Customers.

    Non-GAAP Financial Measures

    We use Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Cost of Goods Sold ("Adjusted COGS"), Adjusted Gross Margin, Adjusted Gross Profit, Adjusted Selling, General, and Administrative Expenses ("Adjusted SG&A"), and Free Cash Flow as important indicators of our operating performance. Collectively, we refer to these non-GAAP financial measures as our "Non-GAAP Measures." The Non-GAAP Measures, when taken collectively with our GAAP results, may be helpful to investors because they provide consistency and comparability with past financial performance and assist in comparisons with other companies, some of which use similar non-GAAP financial information to supplement their GAAP results.

    Adjusted EBITDA is defined as net income (loss) before interest and other income, taxes, and depreciation and amortization as further adjusted for asset impairment costs, stock-based compensation expense and related employer payroll taxes, amortization of cloud-based software implementation costs, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs and major system implementation costs. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by net revenue.

    Adjusted COGS is defined as cost of goods sold adjusted for stock-based compensation expense and related employer payroll taxes.

    Adjusted Gross Profit is defined as net revenue minus Adjusted COGS. Adjusted Gross Margin is defined as Adjusted Gross Profit divided by net revenue.

    Adjusted SG&A is defined as SG&A adjusted for stock-based compensation expense and related employer payroll taxes, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs and major system implementation costs.

    Free Cash Flow is defined as net cash provided by operating activities minus purchases of property and equipment.

    The Non-GAAP Measures are presented for supplemental informational purposes only. A reconciliation of historical GAAP to Non-GAAP financial information is included under "Selected Financial Information" below.

    We have not reconciled our Adjusted EBITDA Margin guidance to GAAP net income (loss) margin, or net margin, or Adjusted EBITDA guidance to GAAP net income (loss) because we do not provide guidance for GAAP net margin or GAAP net income (loss) due to the uncertainty and potential variability of stock-based compensation and taxes, which are reconciling items between GAAP net margin and Adjusted EBITDA Margin and GAAP net income (loss) and Adjusted EBITDA, respectively. Because such items cannot be reasonably provided without unreasonable efforts, we are unable to provide a reconciliation of the Adjusted EBITDA Margin guidance to GAAP net margin and Adjusted EBITDA guidance to GAAP net income (loss). However, such items could have a significant impact on GAAP net margin and GAAP net income (loss).

    About Warby Parker

    Warby Parker (NYSE:WRBY) was founded in 2010 with a mission to inspire and impact the world with vision, purpose, and style–without charging a premium for it. Headquartered in New York City, the co-founder-led lifestyle brand pioneers ideas, designs products, and develops technologies that help people see, from designer-quality prescription glasses (starting at $95) and contacts, to eye exams and vision tests available online and in our 287 retail stores across the U.S. and Canada.

    Warby Parker aims to demonstrate that businesses can scale, do well, and do good in the world. Ultimately, the Company believes in vision for all, which is why for every pair of glasses or sunglasses sold, it distributes a pair to someone in need through its Buy a Pair, Give a Pair program. To date, Warby Parker has worked alongside its nonprofit partners to distribute more than 15 million glasses to people in need.

    Selected Financial Information

    Warby Parker Inc. and Subsidiaries

    Condensed Consolidated Balance Sheets (Unaudited)

    (Amounts in thousands, except par value)

     

     

    March 31,

    2025

     

    December 31, 2024

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    265,074

     

     

    $

    254,161

     

    Accounts receivable, net

     

    1,473

     

     

     

    1,948

     

    Inventory

     

    48,606

     

     

     

    52,345

     

    Prepaid expenses and other current assets

     

    15,444

     

     

     

    17,592

     

    Total current assets

     

    330,597

     

     

     

    326,046

     

     

     

     

     

    Property and equipment, net

     

    173,795

     

     

     

    170,464

     

    Right-of-use lease assets

     

    170,190

     

     

     

    171,284

     

    Other assets

     

    8,173

     

     

     

    8,696

     

    Total assets

    $

    682,755

     

     

    $

    676,490

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    26,546

     

     

    $

    23,519

     

    Accrued expenses

     

    51,796

     

     

     

    51,609

     

    Deferred revenue

     

    22,513

     

     

     

    32,358

     

    Current lease liabilities

     

    18,882

     

     

     

    20,235

     

    Other current liabilities

     

    2,876

     

     

     

    2,633

     

    Total current liabilities

     

    122,613

     

     

     

    130,354

     

     

     

     

     

    Non-current lease liabilities

     

    204,778

     

     

     

    205,120

     

    Other liabilities

     

    1,275

     

     

     

    943

     

    Total liabilities

     

    328,666

     

     

     

    336,417

     

    Commitments and contingencies

     

     

     

    Stockholders' equity:

     

     

     

    Common stock, $0.0001 par value; Class A: 750,000 shares authorized at March 31, 2025 and December 31, 2024, 104,503 and 102,889 issued and outstanding at March 31, 2025 and December 31, 2024, respectively; Class B: 150,000 shares authorized at March 31, 2025 and December 31, 2024, 16,904 and 17,961 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively, convertible to Class A on a one-to-one basis

     

    12

     

     

     

    12

     

    Additional paid-in capital

     

    1,039,755

     

     

     

    1,029,220

     

    Accumulated deficit

     

    (683,749

    )

     

     

    (687,221

    )

    Accumulated other comprehensive loss

     

    (1,929

    )

     

     

    (1,938

    )

    Total stockholders' equity

     

    354,089

     

     

     

    340,073

     

    Total liabilities and stockholders' equity

    $

    682,755

     

     

    $

    676,490

     

    Warby Parker Inc. and Subsidiaries

    Condensed Consolidated Statements of Operations (Unaudited)

    (Amounts in thousands, except per share data)

     

     

    Three Months Ended March 31,

     

    2025

     

    2024

    Net revenue

    $

    223,782

     

    $

    200,003

     

    Cost of goods sold

     

    97,802

     

     

    86,544

     

    Gross profit

     

    125,980

     

     

    113,459

     

     

     

     

     

    Selling, general, and administrative expenses

     

    123,509

     

     

    118,586

     

    Income (loss) from operations

     

    2,471

     

     

    (5,127

    )

     

     

     

     

    Interest and other income, net

     

    2,455

     

     

    2,556

     

     

     

     

     

    Income (loss) before income taxes

     

    4,926

     

     

    (2,571

    )

    Provision for income taxes

     

    1,454

     

     

    108

     

    Net income (loss)

    $

    3,472

     

    $

    (2,679

    )

     

     

     

     

    Earnings per share:

     

     

     

    Basic

    $

    0.03

     

    $

    (0.02

    )

    Diluted

    $

    0.03

     

    $

    (0.02

    )

     

     

     

     

    Weighted average shares outstanding:

     

     

     

    Basic

     

    121,946

     

     

    119,144

     

    Diluted

     

    124,627

     

     

    119,144

     

    Warby Parker Inc. and Subsidiaries

    Condensed Consolidated Statements of Cash Flows (Unaudited)

    (Amounts in thousands)

     

     

    Three Months Ended March 31,

     

    2025

     

    2024

    Cash flows from operating activities

     

     

     

    Net income (loss)

    $

    3,472

     

     

    $

    (2,679

    )

    Adjustments to reconcile net income (loss) to net cash provided by operating activities:

     

     

     

    Depreciation and amortization

     

    12,162

     

     

     

    10,583

     

    Stock-based compensation

     

    12,333

     

     

     

    14,048

     

    Asset impairment charges

     

    311

     

     

     

    399

     

    Amortization of cloud-based software implementation costs

     

    737

     

     

     

    1,073

     

    Change in operating assets and liabilities:

     

     

     

    Accounts receivable, net

     

    475

     

     

     

    612

     

    Inventory

     

    3,739

     

     

     

    5,784

     

    Prepaid expenses and other assets

     

    1,934

     

     

     

    (2,913

    )

    Accounts payable

     

    4,626

     

     

     

    3,327

     

    Accrued expenses

     

    (560

    )

     

     

    (108

    )

    Deferred revenue

     

    (9,845

    )

     

     

    (10,377

    )

    Lease assets and liabilities

     

    (601

    )

     

     

    (263

    )

    Other liabilities

     

    575

     

     

     

    441

     

    Net cash provided by operating activities

     

    29,358

     

     

     

    19,927

     

    Cash flows from investing activities

     

     

     

    Purchases of property and equipment

     

    (16,152

    )

     

     

    (14,437

    )

    Investment in optical equipment company

     

    —

     

     

     

    (2,000

    )

    Net cash used in investing activities

     

    (16,152

    )

     

     

    (16,437

    )

    Cash flows from financing activities

     

     

     

    Proceeds from stock option exercises

     

    39

     

     

     

    91

     

    Shares withheld for taxes on stock-based compensation

     

    (2,341

    )

     

     

    —

     

    Net cash (used in) provided by financing activities

     

    (2,302

    )

     

     

    91

     

    Effect of exchange rates on cash

     

    9

     

     

     

    (91

    )

    Net change in cash and cash equivalents

     

    10,913

     

     

     

    3,490

     

    Cash and cash equivalents, beginning of period

     

    254,161

     

     

     

    216,894

     

    Cash and cash equivalents, end of period

    $

    265,074

     

     

    $

    220,384

     

    Supplemental disclosures

     

     

     

    Cash paid for income taxes

    $

    37

     

     

    $

    69

     

    Cash paid for interest

     

    104

     

     

     

    76

     

    Non-cash investing and financing activities:

     

     

     

    Purchases of property and equipment included in accounts payable and accrued expenses

    $

    4,911

     

     

    $

    4,582

     

    Warby Parker Inc. and Subsidiaries

    Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

    The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to the most directly comparable GAAP measure, which is net loss:

     

    Three Months Ended March 31,

     

    2025

     

    2024

     

    (unaudited, in thousands)

    Net income (loss)

    $

    3,472

     

     

    $

    (2,679

    )

    Adjusted to exclude the following:

     

     

     

    Interest and other income, net

     

    (2,455

    )

     

     

    (2,556

    )

    Provision for income taxes

     

    1,454

     

     

     

    108

     

    Depreciation and amortization expense

     

    12,162

     

     

     

    10,583

     

    Asset impairment charges

     

    311

     

     

     

    399

     

    Stock-based compensation expense(1)

     

    13,001

     

     

     

    14,315

     

    Amortization of cloud-based software implementation costs

     

    737

     

     

     

    1,073

     

    Other costs(2)

     

    525

     

     

     

    1,135

     

    Adjusted EBITDA

    $

    29,207

     

     

    $

    22,378

     

    Adjusted EBITDA Margin

     

    13.1

    %

     

     

    11.2

    %

    (1)

     

    Represents expenses related to the Company's equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions, as well as the issuance of 26,832 and 48,486 Class A common stock to charitable donor advised funds in February 2025 and February 2024, respectively. For the three months ended March 31, 2025 and 2024, the amount includes $0.7 million and $0.3 million, respectively, of employer payroll taxes associated with releases of RSUs and option exercises.

    (2)

     

    Represents charges for certain legal matters outside the ordinary course of business.

    Warby Parker Inc. and Subsidiaries

    Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

    The following table presents our non-GAAP, or adjusted, financial measures for the periods presented as a percentage of revenue. Each cost and operating expense is adjusted for stock-based compensation expense and related employer payroll taxes, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs and major system implementation costs.

     

    Reported

     

    Adjusted

     

    Three Months Ended March 31,

     

    Three Months Ended March 31,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

    Cost of goods sold

    $

    97,802

     

     

    $

    86,544

     

     

    $

    97,529

     

     

    $

    86,300

     

    % of Revenue

     

    43.7

    %

     

     

    43.3

    %

     

     

    43.6

    %

     

     

    43.1

    %

     

     

     

     

     

     

     

     

    Gross profit

    $

    125,980

     

     

    $

    113,459

     

     

    $

    126,253

     

     

    $

    113,703

     

    % of Revenue

     

    56.3

    %

     

     

    56.7

    %

     

     

    56.4

    %

     

     

    56.9

    %

     

     

     

     

     

     

     

     

    Selling, general, and administrative expenses

    $

    123,509

     

     

    $

    118,586

     

     

    $

    110,256

     

     

    $

    103,380

     

    % of Revenue

     

    55.2

    %

     

     

    59.3

    %

     

     

    49.3

    %

     

     

    51.7

    %

    Warby Parker Inc. and Subsidiaries

    Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

    The following table reflects a reconciliation of each non-GAAP, or adjusted, financial measure to its most directly comparable financial measure prepared in accordance with GAAP:

     

    Three Months Ended March 31,

     

     

    2025

     

     

     

    2024

     

     

    (unaudited, in thousands)

    Cost of goods sold

    $

    97,802

     

     

    $

    86,544

     

    Adjusted to exclude the following:

     

     

     

    Stock-based compensation expense(1)

     

    273

     

     

     

    244

     

    Adjusted Cost of Goods Sold

    $

    97,529

     

     

    $

    86,300

     

     

     

     

     

    Gross profit

    $

    125,980

     

     

    $

    113,459

     

    Adjusted to exclude the following:

     

     

     

    Stock-based compensation expense(1)

     

    273

     

     

     

    244

     

    Adjusted Gross Profit

    $

    126,253

     

     

    $

    113,703

     

     

     

     

     

    Selling, general, and administrative expenses

    $

    123,509

     

     

    $

    118,586

     

    Adjusted to exclude the following:

     

     

     

    Stock-based compensation expense(1)

     

    12,728

     

     

     

    14,071

     

    Other costs(2)

     

    525

     

     

     

    1,135

     

    Adjusted Selling, General, and Administrative Expenses

    $

    110,256

     

     

    $

    103,380

     

     

     

     

     

    Net cash provided by operating activities

    $

    29,358

     

     

    $

    19,927

     

    Purchases of property and equipment

     

    (16,152

    )

     

     

    (14,437

    )

    Free Cash Flow

    $

    13,206

     

     

    $

    5,490

     

    (1)

    Represents expenses related to the Company's equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions, as well as the issuance of 26,832 and 48,486 Class A common stock to charitable donor advised funds in February 2025 and February 2024, respectively. For the three months ended March 31, 2025 and 2024, the amount includes $0.7 million and $0.3 million, respectively, of employer payroll taxes associated with releases of RSUs and option exercises.

    (2)

    Represents charges for certain legal matters outside the ordinary course of business.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250508092865/en/

    Investor Relations:

    Jaclyn Berkley, Head of Investor Relations

    Brendon Frey, ICR

    [email protected]

    Media:

    Ali Weltman

    [email protected]

    Get the next $WRBY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WRBY

    DatePrice TargetRatingAnalyst
    4/30/2025$17.00Sell → Neutral
    Citigroup
    4/17/2025$27.00Hold → Buy
    Loop Capital
    2/28/2025$28.00 → $30.00Outperform
    Telsey Advisory Group
    2/25/2025$26.00Neutral
    ROTH MKM
    2/5/2025$19.00 → $23.00Neutral → Sell
    Citigroup
    1/17/2025$23.00Outperform → In-line
    Evercore ISI
    11/19/2024$22.00 → $26.00Outperform
    Telsey Advisory Group
    11/8/2024$19.00 → $22.00Outperform
    Telsey Advisory Group
    More analyst ratings

    $WRBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cutler Joel E disposed of 5,656,571 shares (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      3/18/25 9:52:05 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Chief Financial Officer Miller Steven Clive sold $274,808 worth of shares (11,684 units at $23.52), was granted 15,128 shares, covered exercise/tax liability with 6,321 shares and converted options into 27,731 shares, increasing direct ownership by 14% to 204,727 units (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      3/6/25 6:02:10 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Co-Chief Executive Officer Gilboa David Abraham converted options into 3,271 shares, sold $4,772,513 worth of shares (202,968 units at $23.51), was granted 23,250 shares, covered exercise/tax liability with 12,858 shares and converted options into 201,088 shares, increasing direct ownership by 96% to 24,089 units (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      3/5/25 9:57:41 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    $WRBY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Warby Parker upgraded by Citigroup with a new price target

      Citigroup upgraded Warby Parker from Sell to Neutral and set a new price target of $17.00

      4/30/25 1:18:55 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker upgraded by Loop Capital with a new price target

      Loop Capital upgraded Warby Parker from Hold to Buy and set a new price target of $27.00

      4/17/25 8:27:42 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

      Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $30.00 from $28.00 previously

      2/28/25 8:48:26 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    $WRBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Singer Bradley E bought $965,750 worth of shares (75,000 units at $12.88) (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      8/14/24 4:52:02 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    $WRBY
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $WRBY
    Financials

    Live finance-specific insights

    See more

    $WRBY
    SEC Filings

    See more

    $WRBY
    Leadership Updates

    Live Leadership Updates

    See more

    $WRBY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Warby Parker Announces First Quarter 2025 Results

      Net revenue increased 12% year over year to $224 million Active Customers increased 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2025. "Our team delivered a strong start to 2025. We opened 11 net new stores, exceeded profitability expectations, drove the highest e-commerce growth we've seen since 2021, and delivered our seventh consecutive quarter of accelerating active customer growth," shared Co-Founder and Co-CEO Neil Blumenthal. "Looking to the rest of the year, we'll leverage our diversified suppl

      5/8/25 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2025 will be released before market open on May 8, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 020310. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where presentation

      4/17/25 4:05:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Target and Warby Parker Team Up to Bring Stylish, Affordable Eyewear to More Consumers

      New Warby Parker at Target shop-in-shops will offer guests designer-quality eyewear as well as contacts and eye exams Five shop-in-shops will debut in 2025 with plans to open more in the years aheadMINNEAPOLIS and NEW YORK, Feb. 27, 2025 /PRNewswire/ -- Target Corporation (NYSE:TGT) and Warby Parker (NYSE:WRBY) are partnering to bring designer-quality, affordable eyewear to even more consumers through the retailer's newest shop-in-shop, Warby Parker at Target. Each Warby Parker at Target shop-in-shop will offer products and services — including glasses, sunglasses, contacts, e

      2/27/25 7:15:00 AM ET
      $TGT
      $WRBY
      Department/Specialty Retail Stores
      Consumer Discretionary
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces First Quarter 2025 Results

      Net revenue increased 12% year over year to $224 million Active Customers increased 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2025. "Our team delivered a strong start to 2025. We opened 11 net new stores, exceeded profitability expectations, drove the highest e-commerce growth we've seen since 2021, and delivered our seventh consecutive quarter of accelerating active customer growth," shared Co-Founder and Co-CEO Neil Blumenthal. "Looking to the rest of the year, we'll leverage our diversified suppl

      5/8/25 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2025 will be released before market open on May 8, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 020310. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where presentation

      4/17/25 4:05:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces Fourth Quarter and Full Year 2024 Results

      Q4 net revenue increased 17.8% year over year; 2024 net revenue increased 15.2% year over year Active Customers increased 7.8% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2024. "Our strong 2024 results highlight the power of Warby Parker's brand and unmatched value proposition combined with our team's high-quality execution. We delivered on our ambitious goals to accelerate revenue growth, customer growth and glasses growth, all while maintaining operational discipline and expanding p

      2/27/25 6:45:00 AM ET
      $TGT
      $WRBY
      Department/Specialty Retail Stores
      Consumer Discretionary
      Ophthalmic Goods
      Health Care
    • SEC Form 10-Q filed by Warby Parker Inc.

      10-Q - Warby Parker Inc. (0001504776) (Filer)

      5/8/25 5:10:13 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Warby Parker Inc. (0001504776) (Filer)

      5/8/25 6:46:05 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form DEFA14A filed by Warby Parker Inc.

      DEFA14A - Warby Parker Inc. (0001504776) (Filer)

      5/6/25 5:07:56 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker appoints Ronald A. Williams as Lead Director and welcomes Bradley E. Singer to Board of Directors

      Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company") announced today the appointment of Ron Williams as Lead Director. "Ron's deep expertise in transformational leadership is helping Warby Parker lead the way in making the optical industry more customer and patient friendly. Our shareholders and our team are lucky to have such an exceptional and experienced leader as our first Lead Director," said Neil Blumenthal, co-Founder and co-CEO. The Company has also appointed a new independent director, Brad Singer, to its board of directors. Mr. Singer's appointment is effective today, August 1, 2024. "Brad brings a wealth of experience as a dynamic operator and investor," said Dav

      8/1/24 4:15:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      11/14/24 5:08:23 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      11/14/24 1:30:16 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      11/12/24 10:40:28 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care